Guanhao Biotech Co (SZSE:300238) LT-Debt-to-Total-Asset : 0.07 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Guanhao Biotech Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.07.

Guanhao Biotech Co's long-term debt to total assets ratio increased from Mar. 2023 (0.03) to Mar. 2024 (0.07). It may suggest that Guanhao Biotech Co is progressively becoming more dependent on debt to grow their business.

Guanhao Biotech Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Guanhao Biotech Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co LT-Debt-to-Total-Asset Chart

Guanhao Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.09

0.08

0.03

0.04

Guanhao Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.04	0.07

Guanhao Biotech Co LT-Debt-to-Total-Asset Calculation

Guanhao Biotech Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	24.075	/	678.595
	=	0.04

Guanhao Biotech Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	46.056	/	692.368
	=	0.07

Guanhao Biotech Co (SZSE:300238) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Guanhao Biotech Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co (SZSE:300238) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530

Website

http://www.grandhopebio.com

Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.

Executives

Liu De Wang	Directors, executives
Zhao Jun Hui	Directors, executives
Yang Guo Sheng	Supervisors
Zhu Wei Ping	Director
Hu Jun	Securities Affairs Representative
Jia Bao Rong	Executives
Jia Jun Chao	Executives
Di Pu	Director
Zhuo Fu Min	Director
Guo Xiao Ming	Executives
Zhang Hong Tao	Executives
Zhao Wen Jie	Executives
Guan Xin	Director

Guanhao Biotech Co (SZSE:300238) Headlines

No Headlines